Clinical Trial Update: A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Tolerability of Exenatide in Adolescent Subjects With Type 2 Diabetes Mellitus [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the pharmacokinetics, pharmacodynamics, and tolerability of Exenatide in adolescent subjects with Type 2 Diabetes Mellitus has been c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• EXENATIDE (EXENATIDE)

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED